Report Detail
Global (United States, European Union and China) Glycosylated Peptide Market Research Report 2019-2025
- RnM3689599 |
- 22 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Peptide glycosylation is a covalent modification that can potentially improve the physicochemical properties of peptides.
Some advantages of glycosylated peptides include: (1) increased bioavailability, (2) increased metabolic stability, (2) targeting specific tissues and organs, (3) reduction in clearance rates, (4) enhanced receptor binding, (5) facilitation of active transport across cell membranes (glucose transporters), and (6) maintaining the overall physical properties of peptides (precipitation, aggregation, thermal and kinetic denaturation).
Glycopeptides are recognized as peptides that contain glycans (carbohydrate molecules) and can be generalized classified into three types based on the linkage or bond type between the amino acid and the glycan: (1) C-linked, (2) O-linked, and (3) N-linked.
The most common type in eukaryotic cells is N-linked glycopeptides, noted by the C-N bond from the side chain of asparagine (Asn/N) amino acid. O-Type glycopeptides are named after the C-O bond from the side chains of serine (Ser) and threonine (Thr) amino acids. The least common C-linked types are recognized as the bond between a tryptophan residue and the sugar mannose.
In 2019, the market size of Glycosylated Peptide is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Glycosylated Peptide.
This report studies the global market size of Glycosylated Peptide, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Glycosylated Peptide sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Sandoz International
Pfizer
Roche
Teva Pharmaceuticals Industries
Celltrion
Biocon
Dr.Reddys Laboratories
Medtronic
Cipla
Bachem Americas
Market Segment by Product Type
Monoclonal Antibodies (MABs)
Erythropoietin (EPO)
Others
Market Segment by Application
Oncology
Blood Disorder
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Glycosylated Peptide status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Glycosylated Peptide manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Glycosylated Peptide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Glycosylated Peptide Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Monoclonal Antibodies (MABs)
- 1.3.3 Erythropoietin (EPO)
- 1.3.4 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Glycosylated Peptide Market Share by Application (2019-2025)
- 1.4.2 Oncology
- 1.4.3 Blood Disorder
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Glycosylated Peptide Market Size
- 2.1.1 Global Glycosylated Peptide Revenue 2014-2025
- 2.1.2 Global Glycosylated Peptide Sales 2014-2025
- 2.2 Glycosylated Peptide Growth Rate by Regions
- 2.2.1 Global Glycosylated Peptide Sales by Regions 2014-2019
- 2.2.2 Global Glycosylated Peptide Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Glycosylated Peptide Sales by Manufacturers
- 3.1.1 Glycosylated Peptide Sales by Manufacturers 2014-2019
- 3.1.2 Glycosylated Peptide Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Glycosylated Peptide Revenue by Manufacturers (2014-2019)
- 3.2.2 Glycosylated Peptide Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Glycosylated Peptide Market Concentration Ratio (CR5 and HHI)
- 3.3 Glycosylated Peptide Price by Manufacturers
- 3.4 Key Manufacturers Glycosylated Peptide Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Glycosylated Peptide Market
- 3.6 Key Manufacturers Glycosylated Peptide Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Monoclonal Antibodies (MABs) Sales and Revenue (2014-2019)
- 4.1.2 Erythropoietin (EPO) Sales and Revenue (2014-2019)
- 4.1.3 Others Sales and Revenue (2014-2019)
- 4.2 Global Glycosylated Peptide Sales Market Share by Type
- 4.3 Global Glycosylated Peptide Revenue Market Share by Type
- 4.4 Glycosylated Peptide Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Glycosylated Peptide Sales by Application
6 United States
- 6.1 United States Glycosylated Peptide Breakdown Data by Company
- 6.2 United States Glycosylated Peptide Breakdown Data by Type
- 6.3 United States Glycosylated Peptide Breakdown Data by Application
7 European Union
- 7.1 European Union Glycosylated Peptide Breakdown Data by Company
- 7.2 European Union Glycosylated Peptide Breakdown Data by Type
- 7.3 European Union Glycosylated Peptide Breakdown Data by Application
8 China
- 8.1 China Glycosylated Peptide Breakdown Data by Company
- 8.2 China Glycosylated Peptide Breakdown Data by Type
- 8.3 China Glycosylated Peptide Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Glycosylated Peptide Breakdown Data by Company
- 9.2 Rest of World Glycosylated Peptide Breakdown Data by Type
- 9.3 Rest of World Glycosylated Peptide Breakdown Data by Application
- 9.4 Rest of World Glycosylated Peptide Breakdown Data by Countries
- 9.4.1 Rest of World Glycosylated Peptide Sales by Countries
- 9.4.2 Rest of World Glycosylated Peptide Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Sandoz International
- 10.1.1 Sandoz International Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Glycosylated Peptide
- 10.1.4 Glycosylated Peptide Product Introduction
- 10.1.5 Sandoz International Recent Development
- 10.2 Pfizer
- 10.2.1 Pfizer Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Glycosylated Peptide
- 10.2.4 Glycosylated Peptide Product Introduction
- 10.2.5 Pfizer Recent Development
- 10.3 Roche
- 10.3.1 Roche Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Glycosylated Peptide
- 10.3.4 Glycosylated Peptide Product Introduction
- 10.3.5 Roche Recent Development
- 10.4 Teva Pharmaceuticals Industries
- 10.4.1 Teva Pharmaceuticals Industries Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Glycosylated Peptide
- 10.4.4 Glycosylated Peptide Product Introduction
- 10.4.5 Teva Pharmaceuticals Industries Recent Development
- 10.5 Celltrion
- 10.5.1 Celltrion Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Glycosylated Peptide
- 10.5.4 Glycosylated Peptide Product Introduction
- 10.5.5 Celltrion Recent Development
- 10.6 Biocon
- 10.6.1 Biocon Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Glycosylated Peptide
- 10.6.4 Glycosylated Peptide Product Introduction
- 10.6.5 Biocon Recent Development
- 10.7 Dr.Reddys Laboratories
- 10.7.1 Dr.Reddys Laboratories Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Glycosylated Peptide
- 10.7.4 Glycosylated Peptide Product Introduction
- 10.7.5 Dr.Reddys Laboratories Recent Development
- 10.8 Medtronic
- 10.8.1 Medtronic Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Glycosylated Peptide
- 10.8.4 Glycosylated Peptide Product Introduction
- 10.8.5 Medtronic Recent Development
- 10.9 Cipla
- 10.9.1 Cipla Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Glycosylated Peptide
- 10.9.4 Glycosylated Peptide Product Introduction
- 10.9.5 Cipla Recent Development
- 10.10 Bachem Americas
- 10.10.1 Bachem Americas Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Glycosylated Peptide
- 10.10.4 Glycosylated Peptide Product Introduction
- 10.10.5 Bachem Americas Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Glycosylated Peptide Sales Channels
- 11.2.2 Glycosylated Peptide Distributors
- 11.3 Glycosylated Peptide Customers
12 Market Forecast
- 12.1 Global Glycosylated Peptide Sales and Revenue Forecast 2019-2025
- 12.2 Global Glycosylated Peptide Sales Forecast by Type
- 12.3 Global Glycosylated Peptide Sales Forecast by Application
- 12.4 Glycosylated Peptide Forecast by Regions
- 12.4.1 Global Glycosylated Peptide Sales Forecast by Regions 2019-2025
- 12.4.2 Global Glycosylated Peptide Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Glycosylated Peptide. Industry analysis & Market Report on Glycosylated Peptide is a syndicated market report, published as Global (United States, European Union and China) Glycosylated Peptide Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Glycosylated Peptide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
